FDA Drug recall D-1062-2016
Cyproheptadine Hydrochloride Syrup, Oral Solution USP, 2 mg/5 mL, packaged in an amber glass 473 mL (one pint) bottle with child-resistant…
- FDA Drug
- Class III
- terminated
- Published 2016-07-13
On 2016-07-13 the FDA classified a Class III recall of Cyproheptadine Hydrochloride Syrup, Oral Solution USP, 2 mg/5 mL, packaged in an amber glass 473 mL (one pint) bottle with child-resistant… by Lyne Laboratories, citing subpotency: product assayed and found OOS for cyproheptadine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1062-2016 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-06-07 |
| Published | 2016-07-13 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Lyne Laboratories |
| Distribution | NJ |
Product
Cyproheptadine Hydrochloride Syrup, Oral Solution USP, 2 mg/5 mL, packaged in an amber glass 473 mL (one pint) bottle with child-resistant screw closure, Rx only, Distributed by: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Manufactured by: Lyne Laboratories, Inc., Brockton, MA 02301, NDC 64980-0504-48
Reason
Subpotency: product assayed and found OOS for cyproheptadine
Identifiers
| code_info | Lot #: CR1603, Exp 12/17 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1062-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.